Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An announcement from Pharmaxis Ltd ( (AU:SNT) ) is now available.
Syntara Limited has announced a new issuance of 162,000 ordinary fully paid securities, which will be quoted on the Australian Securities Exchange (ASX) under the code SNT. This move reflects the company’s ongoing efforts to enhance its market presence and potentially increase its capital base, signaling a strategic step in its growth trajectory.
The most recent analyst rating on (AU:SNT) stock is a Buy with a A$0.12 price target. To see the full list of analyst forecasts on Pharmaxis Ltd stock, see the AU:SNT Stock Forecast page.
More about Pharmaxis Ltd
Average Trading Volume: 9,806,455
Technical Sentiment Signal: Hold
Current Market Cap: A$91.14M
For a thorough assessment of SNT stock, go to TipRanks’ Stock Analysis page.